LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

Search

CytomX Therapeutics Inc

Slēgts

SektorsVeselības aprūpe

3

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

2.98

Max

3.02

Galvenie mērījumi

By Trading Economics

Ienākumi

8.3M

-18M

Pārdošana

9.6M

10M

P/E

Sektora vidējais

22.5

49.052

EPS

-0.1

Peļņas marža

-177.89

Darbinieki

69

EBITDA

8M

-19M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+308.64% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 6. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-270M

640M

Iepriekšējā atvēršanas cena

3

Iepriekšējā slēgšanas cena

3

Ziņu noskaņojums

By Acuity

50%

50%

156 / 344 Rangs Healthcare

CytomX Therapeutics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 12. jūn. 23:06 UTC

Social Media
News
ETF Constituents

Invesco QQQ Trust Series I gains after-market, supported by a strong Nasdaq close and SpaceX's debut, maintaining stability since Friday's close.

2026. g. 12. jūn. 20:07 UTC

News
Correlated Moves

The USD/DKK is trading higher, reflecting a modest increase since Thursday's close. The US Dollar Index also shows a slight uptick.

2026. g. 12. jūn. 20:07 UTC

News

The USD/CZK is trading lower today, reflecting a slight decline since Thursday's close. Recent U.S. producer price data has not significantly impacted the currency pair.

2026. g. 12. jūn. 20:07 UTC

News

Baker Hughes oil rig count rises to 433, influencing energy market sentiment. USD/PLN is trading roughly flat during Friday's session.

2026. g. 12. jūn. 20:07 UTC

Correlated Moves
Macro Event
News

The U.S. Baker Hughes oil rig count increased to 433, while the Michigan Consumer Sentiment Index rose to a preliminary reading of 48.9. USD/SGD is trading roughly flat.

2026. g. 12. jūn. 20:07 UTC

News

The U.S. Baker Hughes oil rig count rose to 433, while USD/THB trades roughly flat since Thursday's close amid routine market fluctuations.

2026. g. 12. jūn. 20:07 UTC

News
Macro Event

The USD/SEK exchange rate is lower today, despite a rise in U.S. consumer sentiment reported at 48.9, above expectations.

2026. g. 12. jūn. 20:07 UTC

News
Macro Event

USD/HUF trades lower despite a stronger-than-expected Michigan Consumer Sentiment Index, reflecting ongoing inflation concerns and unusual volatility during the session.

2026. g. 12. jūn. 20:07 UTC

News

The USD/ZAR is higher, supported by an increase in the Baker Hughes oil rig count, reflecting dynamics in the energy sector impacting currency valuations.

2026. g. 12. jūn. 20:02 UTC

News

ASML Holding NV is lower today, even as analysts note strengthening competitive advantages amid diminishing concerns over rival xLight and ongoing demand for its technology.

2026. g. 12. jūn. 20:02 UTC

News

Amazon.com Inc. shares are declining amid broadline retail sector weakness, despite recognition of Amazon Web Services as a growth driver.

2026. g. 12. jūn. 20:02 UTC

Macro Event
ETF Constituents
News
Macro News
Correlated Moves
Social Media

Financial Select Sector SPDR Fund is higher today, supported by gains in the financial sector and optimism over geopolitical stability following President Trump's Iran negotiations.

2026. g. 12. jūn. 20:02 UTC

News
Social Media

Intel's stock rises as Bank of America upgrades to Buy and Google orders three million processing units, reflecting strong market sentiment and bullish options flow.

2026. g. 12. jūn. 20:02 UTC

News

Cintas Corp shares are lower as the FTC issues a second request regarding its acquisition of UniFirst, signaling potential delays in the transaction.

2026. g. 12. jūn. 20:02 UTC

News

Adobe Inc. shares are trading lower amid analyst downgrades and CFO Dan Durn's upcoming departure. Concerns over a freemium model pressure near-term revenue outlook.

2026. g. 12. jūn. 20:01 UTC

News

Speculation about a merger involving Deutsche Telekom has boosted T-Mobile US shares. The stock has shown steady gains since Thursday's close, trading above its 20-day moving average.

2026. g. 12. jūn. 19:56 UTC

News
Correlated Moves
Macro Event

Broadcom Inc shares declined as broader market dynamics and economic data weighed on sentiment, despite record Q2 revenue and AI growth.

2026. g. 12. jūn. 19:52 UTC

News
Social Media

Workday Inc shares are lower today amid broader declines in the Application Software sector and an insider selling 107,500 shares at $135.54 to $140.37.

2026. g. 12. jūn. 19:52 UTC

News
Correlated Moves
Social Media

Wells Fargo raised Qualcomm's price target to $230, contributing to positive sentiment. The stock is trading higher amid optimism for upcoming Investor Day.

2026. g. 12. jūn. 19:52 UTC

News

Intuit Inc. shares are lower amid an investigation for securities fraud by Bleichmar Fonti & Auld LLP related to pricing issues for DIY tax filers.

2026. g. 12. jūn. 19:51 UTC

News

Amgen Inc. is reassessing data on Tavneos amid FDA scrutiny. Shares are higher as the company challenges the proposal to withdraw the drug's approval.

2026. g. 12. jūn. 19:51 UTC

News
ETF Constituents

Health Care Select Sector SPDR Fund declines as key holdings falter, underperforming against gains in Energy, Materials, and Financials sectors.

2026. g. 12. jūn. 19:46 UTC

News
Social Media

Alphabet appeals a German court ruling on AI claims and announced a $50 million investment in workforce training, while shares are higher today.

2026. g. 12. jūn. 19:42 UTC

News
Social Media

Meta Platforms shares are lower amid reports of widespread service outages affecting Instagram, Facebook, and WhatsApp, with over 62,000 complaints noted.

2026. g. 12. jūn. 19:41 UTC

News

Analysts have raised earnings estimates for NetEase, reflecting positive sentiment. Shares are trading higher today, maintaining upward momentum since Thursday's close.

2026. g. 12. jūn. 19:41 UTC

News
Correlated Moves
Social Media

Advanced Micro Devices shares rose after Citi upgraded its rating to Buy and raised the price target to $575, citing strong GPU market potential.

2026. g. 12. jūn. 19:41 UTC

News
Correlated Moves

Applied Materials Inc is rising amid a broader market rally and Cantor Fitzgerald's price target increase to $650 from $575, reflecting strong investor interest.

2026. g. 12. jūn. 19:41 UTC

Social Media
News

WDC shares gain as JPMorgan raises price target to $650.

2026. g. 12. jūn. 19:41 UTC

Social Media
News
Correlated Moves
Macro Event

Lam Research Corp shares rise amid a market rally following President Trump's strike cancellation on Iran. Cantor Fitzgerald raised its price target to $425.

2026. g. 12. jūn. 19:41 UTC

News

Comcast Corp shares are higher today, driven by gains in the Cable & Satellite sector. The stock remains above Thursday's close despite a slight pullback.

Salīdzinājums

Cenas izmaiņa

CytomX Therapeutics Inc Prognoze

Cenas mērķis

By TipRanks

308.64% augšup

Prognoze 12 mēnešiem

Vidējais 12.3 USD  308.64%

Augstākais 16 USD

Zemākais 6 USD

Pamatojoties uz 10 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi CytomX Therapeutics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

10 ratings

10

Pirkt

0

Turēt

0

Pārdot

Noskaņojums

By Acuity

156 / 344 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par CytomX Therapeutics Inc

CytomX Therapeutics, Inc., an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and development comprising the validation of targets for antibody-drug conjugates (ADCs), opening therapeutic window for novel T-cell engagers (TCEs) targeting solid tumors, and increasing the therapeutic index for immune modulators, such as cytokines; and PROBODY platform in preclinical research in areas outside of oncology. It also develops CX-904, a T-cell-engaging bispecific antibody targeting the epidermal growth factor receptor (EGFR) on tumor cells and the CD3 receptor on T cells; CX-2051, a conditionally activated ADC for optimizing the therapeutic index for EpCAM-expressing epithelial cancers, including colorectal cancer; and CX-801, an interferon alpha-2b PROBODY cytokine. In addition, the company's development pipeline comprises CX-2029, a conditional activated ADC targeting CD71; and BMS-986288, a PROBODY version of non-fucosylated ipilimumab. It has strategic collaborations with Amgen, Astellas, Bristol Myers Squibb, Regeneron, and Moderna; and clinical trial collaboration and supply agreement with Merck for the evaluation of CX-801 in combination with anti-PD-1 therapy, KEYTRUDA (pembrolizumab). CytomX Therapeutics, Inc. was founded in 2008 and is headquartered in South San Francisco, California.
help-icon Live chat